These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

955 related items for PubMed ID: 9877269

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnostic significance of the number of bone marrow megakaryocytes in cases with decreased platelet production evidenced by platelet kinetic study].
    Tsukada T, Ueyama J, Miyakoshi S, Morinaga S, Mutoh Y, Yamaguchi H, Matsuya S.
    Rinsho Ketsueki; 1990 Jul; 31(7):903-10. PubMed ID: 2214187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
    Thomas-Kaskel AK, Mattern D, Köhler G, Finke J, Behringer D.
    Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
    Zhang XH, Wang GX, Zhu HH, Liu YR, Xu LP, Han W, Chen H, Chen YH, Wang FR, Wang JZ, Wang Y, Zhao T, Chen Y, Feng R, Fu HX, Wang M, Zhou Y, Lv M, Liu KY, Huang XJ.
    Ann Hematol; 2015 Oct; 94(10):1689-98. PubMed ID: 26141368
    [Abstract] [Full Text] [Related]

  • 12. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
    Drayer AL, Smit Sibinga CT, Esselink MT, de Wolf JT, Vellenga E.
    Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
    [Abstract] [Full Text] [Related]

  • 13. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D, Martino R, Sureda A, Canals C, Altés A, Briones J, Sanz MA, Parody R, Constans M, Villela SL, Brunet S, Sierra J.
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [Abstract] [Full Text] [Related]

  • 14. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
    Lee J, Kook H, Chung I, Kim H, Park M, Kim C, Nah J, Hwang T.
    Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
    [Abstract] [Full Text] [Related]

  • 15. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW, Wu DP, Sun AN, Feng YF, Chang WR, Zhu ZL, Zhu P.
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [Abstract] [Full Text] [Related]

  • 16. [Prolonged thrombocytopenia after autologous bone marrow transplantation].
    Kojima S, Fukuda M, Horibe K, Matsuyama T, Takeyama K, Matsushita T, Miyamura K, Sugihara T, Minami S, Kodera Y.
    Rinsho Ketsueki; 1989 Feb; 30(2):175-80. PubMed ID: 2664261
    [Abstract] [Full Text] [Related]

  • 17. Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells.
    Lopez M, Mortel O, Pouillart P, Zucker JM, Fechtenbaum J, Douay L, Palangie T, Michon J, Salmon D, Gorin NC.
    Bone Marrow Transplant; 1991 Mar; 7(3):173-81. PubMed ID: 1676321
    [Abstract] [Full Text] [Related]

  • 18. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW, Basara N, Bischoff M, Günzelmann S, Römer E, Kirsten D, Schmetzer B, Kiehl MG, Fauser AA.
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.